Neuropsychiatric Symptoms and Alzheimer's Disease Biomarkers Predict Driving Decline: Brief Report.

Abstract

We examined whether neuropsychiatric symptoms (NPS) interact with cerebrospinal fluid (CSF) biomarkers (amyloid-β42 [Aβ42], tau, phosphorylated tau181 [ptau181], tau/Aβ42, and ptau181/Aβ42) of Alzheimer's disease pathology to predict driving decline among cognitively-normal older adults (N = 116) aged ≥65. Cox proportional hazards models examined time to… (More)
DOI: 10.3233/JAD-170067

Topics

2 Figures and Tables

Cite this paper

@article{Babulal2017NeuropsychiatricSA, title={Neuropsychiatric Symptoms and Alzheimer's Disease Biomarkers Predict Driving Decline: Brief Report.}, author={Ganesh Muneshwar Babulal and Sarah H. Stout and Denise Head and David M Holtzman and Anne M. Fagan and John C. Morris and Catherine M. Roe}, journal={Journal of Alzheimer's disease : JAD}, year={2017}, volume={58 3}, pages={675-680} }